Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer

MichelsJ.; VitaleI.; SenovillaL.; EnotD.P.; GarciaP.; LissaD.; OlaussenK.A.; BrennerC.; SoriaJ.-C.; CastedoM.; KroemerG.

首页> 外文期刊>Cell cycle >Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer

【24h】

Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer

机译：非小细胞肺癌中顺铂与PARP抑制剂的协同相互作用

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Abbreviations: CDDP, cisplatin; CEP, CEP 8983; DiOC6(3), 3′-dihexyloxacarbocyanine iodide; Δψm, mitochondrial transmembrane potential; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NSCLC, non-small cell lung carcinoma; PARP, poly(ADP-ribose) polymerase; PI, propidium iodide; PJ, PJ34 hydrochloride hydrate; siRNA, small-interfering RNA.

机译：缩写：CDDP，顺铂; CEP，CEP 8983; DiOC6（3），3'-二己基氧杂碳菁碘化物; Δψm，线粒体跨膜电位; GAPDH，3-磷酸甘油醛脱氢酶;非小细胞肺癌，非小细胞肺癌; PARP，聚（ADP-核糖）聚合酶; PI，碘化丙啶; PJ，PJ34盐酸盐水合物; siRNA，小干扰RNA。

著录项

来源
《Cell cycle》 |2013年第6期|共7页
作者
MichelsJ.; VitaleI.; SenovillaL.; EnotD.P.; GarciaP.; LissaD.; OlaussenK.A.; BrennerC.; SoriaJ.-C.; CastedoM.; KroemerG.;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类细胞生物学;
关键词
A549 cells; Apoptosis; CEP 8983; DNA damage response; PJ34 hydrochloride; Small-interfering RNAd;

机译：A549细胞;凋亡;CEP 8983;DNA损伤反应;PJ34盐酸盐;小干扰RNA;

相似文献

外文文献
中文文献
专利

1. Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer [J] . MichelsJ., VitaleI., SenovillaL., Cell cycle . 2013,第6期

机译：非小细胞肺癌中顺铂与PARP抑制剂的协同相互作用
2. PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells [J] . ChengH., ZhangZ., BorczukA., Carcinogenesis . 2013,第4期

机译：PARP抑制选择性增加ERCC1低非小细胞肺癌细胞对顺铂的敏感性
3. Safety and resource utilization by non-small cell lung cancer histology: results from the randomized phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with advanced non-small cell lung cancer. [J] . Novello S, Pimentel FL, Douillard JY, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2010,第10期

机译：非小细胞肺癌组织学的安全性和资源利用：培美曲塞加顺铂与吉西他滨加顺铂在晚期非小细胞肺癌化疗放化疗患者中进行的随机III期研究结果。
4. Profiling EGFR Kinase Inhibitor Resistance Pathways in Non-Small Lung Cancer Cells [C] . Ryan D. Bomgarden, Ryan Jacobs, Jason Fong, ASMS Conference on Mass Spectrometry and Allied Topics . 2014

机译：在非小肺癌细胞中的谱分析EGFR激酶抑制剂抵抗途径
5. Enhancing the Therapeutic Effects of Low Doses of Ionizing Radiation in Non-Small Cell Lung Cancers Using a Combination of PARP Inhibitors and DNA Demethylating Agents. [D] . Biondi, Christopher Anthony. 2016

机译：使用PARP抑制剂和DNA去甲基化剂的组合增强非小细胞肺癌低剂量电离辐射的治疗效果。
6. Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer [O] . Judith Michels, Ilio Vitale, Laura Senovilla, 2013

机译：非小细胞肺癌中顺铂与PARP抑制剂的协同相互作用
7. Synergistic effects of type I PRMT and PARP inhibitors against non-small cell lung cancer cells [O] . Claudia Dominici, Nicolas Sgarioto, Zhenbao Yu, 2021

机译：I型PRMT和PARP抑制剂对非小细胞肺癌细胞的协同作用

Synergistic interaction between cisplatin and PARP inhibitors in non-small cell lung cancer

摘要

著录项

相似文献

相关主题

期刊订阅